KEROS THERAPEUTICS, INC. (KROS)
Keros Therapeutics Appoints Anne Prener to its Board of Directors
Keros Therapeutics Appoints Anne Prener to its Board of Directors
Taysha Gene Therapies Announces Multiple Presentations Highlighting its TSHA-102 Clinical Program at the 2026 IRSF Rett Syndrome Scientific Meeting
Truist announces release of 2026 CCAR results
Wise Group plc reports Full Year 2026 Financial Results
McGrath Second Quarter Earnings and Conference Call Scheduled for July 29, 2026
Ascendis to Showcase Advances in Treatment of Achondroplasia at ICCBH 2026
Ligand Announces Closing of Convertible Senior Notes Offering
Salesforce Grants Equity Awards to Momentum Under Its Inducement Equity Incentive Plan
MKS Expanding Manufacturing Capability to Enable Next Wave of AI Build-Out
Lattice Wins 2026 AI Breakthrough Award